Coronary heart disease risk factors and menopause:: A study in 1684 French women

被引:103
作者
Trémollières, FA [1 ]
Pouilles, JM [1 ]
Cauneille, C [1 ]
Ribot, C [1 ]
机构
[1] CHU Rangueil, Dept Endocrinol, Menopause & Metab Dis Unit, F-31403 Toulouse 4, France
关键词
menopause; coronary heart disease; cardio-vascular risk factor; hypertension; hypercholesterolemia;
D O I
10.1016/S0021-9150(98)00252-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aimed to assess the relationship between menopause and various risk factors for coronary heart diseases (CHD) in a large sample of French women aged 45-65 years. One thousand six hundred and eighty-four consecutive healthy women who received a systematic check-up in our Menopause Unit were included in this study. All the women answered a computer-assisted questionnaire which comprised 156 items, 72 questions being exclusively related to the identification of familial and personal cardio-vascular risk factors. Biological measurements were performed to evaluate lipid-lipoprotein profile and fasting glucose levels. Women, none of whom were treated with hormonal replacement therapy, were classified as postmenopausal according to the date of their last menses and levels of serum FSH and estradiol (n = 1200). Perimenopausal women were further subdivided into two subgroups according to the regularity of their menstrual cycles and FSH levels (early (n = 143) and late (n = 341) perimenopause). 12% (n = 205) of the women were currently receiving lipid-lowering drugs (84.4% postmenopausal vs. 15.6% perimenopausal). When all women were considered, menopause was associated with a higher prevalence of hypertension and hypercholesterolemia (serum total cholesterol level > 250 mg/dl + LDL cholesterol level > 160 mg/dl). This higher prevalence in postmenopausal women was also found when the analysis was restricted to women aged 45-55 years, which rather suggests an effect of menopause than of age. Of the women not receiving hypolipidemic treatments, postmenopausal women had significantly higher serum levels of total cholesterol, LDL, VLDL cholesterol, triglycerides and apolipoprotein B and lower levels of HDL cholesterol than perimenopausal women. Multivariate analysis indicated that these effects were independent of age, body mass index and years since menopause. The prevalence of other metabolic disturbances was much more lower. On average, perimenopausal women had significantly less CHD risk factors than postmenopausal women (P < 0.0001). Fifty-two per cent of the perimenopausal women had none of the risk factors studied as compared with 39% of the postmenopausal women (P < 0.0001). This study shows that menopause was associated with a higher prevalence of risk factors for CHD. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:415 / 423
页数:9
相关论文
共 34 条
[1]  
ADAMS MR, 1990, ARTERIOSCLEROSIS, V10, P151
[2]   ESTROGEN AND CORONARY HEART-DISEASE IN WOMEN [J].
BARRETTCONNOR, E ;
BUSH, TL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (14) :1861-1867
[3]   CARDIOVASCULAR MORTALITY AND NONCONTRACEPTIVE USE OF ESTROGEN IN WOMEN - RESULTS FROM THE LIPID RESEARCH CLINICS PROGRAM FOLLOW-UP-STUDY [J].
BUSH, TL ;
BARRETTCONNOR, E ;
COWAN, LD ;
CRIQUI, MH ;
WALLACE, RB ;
SUCHINDRAN, CM ;
TYROLER, HA ;
RIFKIND, BM .
CIRCULATION, 1987, 75 (06) :1102-1109
[4]   DIFFERENCES IN LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND APOLIPOPROTEINS IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN [J].
CAMPOS, H ;
MCNAMARA, JR ;
WILSON, PWF ;
ORDOVAS, JM ;
SCHAEFER, EJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) :30-35
[5]   MENOPAUSE AND THE RISK OF CORONARY HEART-DISEASE IN WOMEN [J].
COLDITZ, GA ;
WILLETT, WC ;
STAMPFER, MJ ;
ROSNER, B ;
SPEIZER, FE ;
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (18) :1105-1110
[6]   MULTIPLE CORONARY HEART-DISEASE RISK-FACTORS ARE ASSOCIATED WITH MENOPAUSE AND INFLUENCED BY SUBSTITUTIVE HORMONAL-THERAPY IN A COHORT OF FRENCH WOMEN [J].
DALLONGEVILLE, J ;
MARECAUX, N ;
ISOREZ, D ;
ZYLBERBERG, G ;
FRUCHART, JC ;
AMOUYEL, P .
ATHEROSCLEROSIS, 1995, 118 (01) :123-133
[7]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[8]  
GANGAR KF, 1991, LANCET, V338, P839
[9]   INSULIN-RESISTANCE, SECRETION, AND ELIMINATION IN POSTMENOPAUSAL WOMEN RECEIVING ORAL OR TRANSDERMAL HORMONE REPLACEMENT THERAPY [J].
GODSLAND, IF ;
GANGAR, K ;
WALTON, C ;
CUST, MP ;
WHITEHEAD, MI ;
WYNN, V ;
STEVENSON, JC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (07) :846-853
[10]   MENOPAUSE AND CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
KANNEL, WB ;
HJORTLAND, MC ;
MCNAMARA, PM .
ANNALS OF INTERNAL MEDICINE, 1978, 89 (02) :157-161